The Impact of Estrogen Deficiency Symptoms on Health-Related Quality of Life in Menopausal-Aged Women in China
<p id="p1">Menopausal symptoms are a critical health issue as they can have a substantial detrimental effect on women’s physical and mental health and substantially impair health-related quality of life (HRQoL). Vasomotor symptoms (VMS) such as hot flushes, sweating, sleep disturbances, irrita...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2025
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/1207186 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | <p id="p1">Menopausal symptoms are a critical health issue as they can have a substantial detrimental effect on women’s physical and mental health and substantially impair health-related quality of life (HRQoL). Vasomotor symptoms (VMS) such as hot flushes, sweating, sleep disturbances, irritability, anxiety, and depression are often considered the cardinal symptoms of menopause. Among Chinese women of menopausal age, the symptom burden is high, with hot flushes/sweating, sleep disorders, mood disorders, and fatigue reported to be prevalent. In this chapter, we describe the available data on the burden of menopausal symptoms across pre-, peri-, and post-menopausal phases among Chinese women and the impact of these symptoms on HRQoL. We provide an overview of the recommendation for estrogen-based menopausal hormone therapy for the treatment of estrogen deficiency symptoms, given in combination with progestogen for non-hysterectomized women. We also describe the benefits of estradiol plus dydrogesterone among postmenopausal women of Chinese ethnicity, which include consistent improvements in symptom frequency and severity and improvements in HRQoL. Finally, we highlight the importance of timely identification and management of menopausal symptoms among Chinese women and the need to increase awareness of menopausal hormone therapy in this population.</p> |
|---|---|
| ISBN: | 978-1-83634-344-8 |
| DOI: | 10.5772/intechopen.1008518 |